{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"14.7","upperLimit":"94.7","value":"60.0"},{"groupId":"OG001","lowerLimit":"35.9","upperLimit":"99.6","value":"83.3"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"description":"Objective Response Rate (ORR) is defined as the percentage of participants with CR or PR according to the modified Lugano Criteria for Response Assessment (Cheson 2014) based on investigator assessment","dispersionType":"95% Confidence Interval","groups":[{"description":"Participants with classic Hodgkin lymphoma","id":"OG000","title":"Classic Hodgkin Lymphoma"},{"description":"Participants with peripheral T cell lymphoma","id":"OG001","title":"PTCL"}],"paramType":"NUMBER","populationDescription":"The full analysis set includes participants who received at least one dose of study treatment.","reportingStatus":"POSTED","timeFrame":"Up to 18.3 months","title":"ORR Per Investigator Assessment According to Modified Lugano Response Criteria","type":"SECONDARY","unitOfMeasure":"Percentage of Participants"}